Tidemark, LLC

SEC CIK: 0002009591
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Tidemark, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overview All 13F holders of LGND Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2023

Holdings of LGND by Tidemark, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−4−100.0%	Sold out	Holders
Q2 2024	4	$337	<0.1%	00.0%	Unchanged	Holders
Q1 2024	4	$292	<0.1%	00.0%	Unchanged	Holders
Q4 2023	4	$286	<0.1%	–	No prior filing	Holders